PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 83.5

(0.6%)

Gross Profit Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual gross profit in 2023 was -26.14 Million TWD , down -69.64% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly gross profit in 2024 Q1 was -14.75 Million TWD , down -299.81% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported a annual gross profit of -42.29 Million TWD in annual gross profit 2022, down -22.49% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported a annual gross profit of -34.53 Million TWD in annual gross profit 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported a quarterly gross profit of -14.75 Million TWD for 2024 Q1, down -299.81% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported a quarterly gross profit of -10.62 Million TWD for 2023 Q3, up 50.59% from previous quarter.

Annual Gross Profit Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Historical Annual Gross Profit of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Gross Profit Gross Profit Growth
2023 -26.14 Million TWD -69.64%
2022 -42.29 Million TWD -22.49%
2021 -34.53 Million TWD 0.0%

Peer Gross Profit Comparison of PELL Bio-Med Technology Co. Ltd.

Name Gross Profit Gross Profit Difference
Apex Biotechnology Corp. 531.11 Million TWD 104.922%
Sinphar Pharmaceutical Co.,Ltd. 1.09 Billion TWD 102.395%
Panion & Bf Biotech Inc. 912.56 Million TWD 102.864%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 757.3 Million TWD 103.452%
GenMont Biotech Incorporation 177.33 Million TWD 114.74%
Abnova (Taiwan) Corporation 173.91 Million TWD 115.03%
Adimmune Corporation 410.93 Million TWD 106.361%
Tanvex BioPharma, Inc. 59.7 Million TWD 143.785%
Polaris Group -137.9 Million TWD 81.044%
Energenesis Biomedical CO.,LTD. 5.22 Million TWD 600.096%
UnicoCell Biomed Co., Ltd. 17.89 Million TWD 246.058%